Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps
- PMID: 17882425
- DOI: 10.1007/s00330-007-0766-z
Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps
Abstract
Purpose: To assess the diagnostic accuracy of contrast-enhanced 3.0-T breast magnetic resonance imaging (MRI) for differentiating benign from malignant breast masses and subsequently to test if specificity could be further improved by scoring of the overall ipsilateral breast vascularity.
Materials and methods: Fifty-four patients were prospectively enrolled in the study and underwent contrast-enhanced 3.0-T breast MRI. MR images were evaluated and classified according to the MRI BI-RADS lexicon criteria. Lesion size, number of lesions, and localization in the breast were systematically assessed. Maximum intensity projections (MIPS) were obtained by using high-resolution contrast-enhanced (0.1 mmol/kg gadobutrol) fat-saturated T1-weighted images. Breast vascularization was scored according to the methods from Sardanelli et al. by measuring the number, diameter, and length of the vessels on the MIPS. The score ranged from 0 (indicating absent or low breast vascularity) to 3 (indicating high breast vascularity).
Results: Final analysis of 56 lesions revealed 25 (45%) malignant lesions and 31 (55%) benign lesions. Correlation with the MRI BI-RADS classification revealed cancer in none (0%) of the BI-RADS II lesions, in 1 (12%) of the BI-RADS III lesions, in 5 (83%) of the BI-RADS IV lesions, and in 19 (100%) of the BI-RADS V lesions. Based on morphologic and kinetic data analysis, the sensitivity and specificity of 3.0-T breast MRI was 100% (25/25) and 74% (23/31), respectively. After adjustment for the breast vascularity score, specificity significantly (p = 0.048) increased to 87% (27/31) without affecting sensitivity.
Conclusion: Diagnostic accuracy of contrast-enhanced 3.0-T breast MRI increased significantly when the vascularity score was added to the standard morphologic and kinetic data analysis, resulting in a specificity of 87% without affecting sensitivity, which remained 100%.
Similar articles
-
Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.Radiology. 2007 Jun;243(3):670-80. doi: 10.1148/radiol.2433060838. Epub 2007 Apr 19. Radiology. 2007. PMID: 17446524
-
Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.Radiology. 2005 Jun;235(3):791-7. doi: 10.1148/radiol.2353040733. Epub 2005 Apr 21. Radiology. 2005. PMID: 15845796 Clinical Trial.
-
Investigation of imaging features in contrast-enhanced magnetic resonance imaging of benign and malignant breast lesions.Jpn J Radiol. 2024 Jul;42(7):720-730. doi: 10.1007/s11604-024-01551-1. Epub 2024 Mar 20. Jpn J Radiol. 2024. PMID: 38503998 Free PMC article.
-
The specificity of contrast-enhanced breast MR imaging.Magn Reson Imaging Clin N Am. 1994 Nov;2(4):557-71. Magn Reson Imaging Clin N Am. 1994. PMID: 7489308 Review.
-
Contrast-enhanced breast MRI: factors affecting sensitivity and specificity.Eur Radiol. 1997;7 Suppl 5:281-8. doi: 10.1007/pl00006909. Eur Radiol. 1997. PMID: 9370560 Review.
Cited by
-
Bilateral analysis of the cross-sectional area of the internal mammary arteries and veins in patients with and without breast cancer on breast magnetic resonance imaging.Insights Imaging. 2013 Apr;4(2):177-84. doi: 10.1007/s13244-012-0214-8. Epub 2013 Jan 16. Insights Imaging. 2013. PMID: 23322271 Free PMC article.
-
Dynamic Evolution of Vascular Features Based on Magnetic Resonance Imaging to Predict Pathological Response, Patterns of Recurrence and Survival Outcomes in Breast Cancer Neoadjuvant Chemotherapy.Curr Oncol. 2025 Jun 13;32(6):350. doi: 10.3390/curroncol32060350. Curr Oncol. 2025. PMID: 40558293 Free PMC article.
-
Diagnostic value of Kaiser score combined with breast vascular assessment from breast MRI for the characterization of breast lesions.Front Oncol. 2023 Jul 6;13:1165405. doi: 10.3389/fonc.2023.1165405. eCollection 2023. Front Oncol. 2023. PMID: 37483510 Free PMC article.
-
Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors.Magn Reson Med. 2019 Mar;81(3):2147-2160. doi: 10.1002/mrm.27529. Epub 2018 Oct 28. Magn Reson Med. 2019. PMID: 30368906 Free PMC article.
-
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.Eur Radiol. 2014 Apr;24(4):913-20. doi: 10.1007/s00330-013-3075-8. Epub 2013 Dec 5. Eur Radiol. 2014. PMID: 24306425 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical